These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 737897)

  • 21. Association between nuclear antigens and endogenous retrovirus in the generation of autoantibody responses in murine lupus.
    Tucker RM; Roark CL; Santiago-Raber ML; Izui S; Kotzin BL
    Arthritis Rheum; 2004 Nov; 50(11):3626-36. PubMed ID: 15529369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic administration of interleukin-4 expressing plasmid DNA delays the development of glomerulonephritis and prolongs survival in lupus-prone female NZB x NZW F1 mice.
    Hayashi T; Hasegawa K; Sasaki Y; Mori T; Adachi C; Maeda K
    Nephrol Dial Transplant; 2007 Nov; 22(11):3131-8. PubMed ID: 17670770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-6 exacerbates glomerulonephritis in (NZB x NZW)F1 mice.
    Ryffel B; Car BD; Gunn H; Roman D; Hiestand P; Mihatsch MJ
    Am J Pathol; 1994 May; 144(5):927-37. PubMed ID: 8178944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressive oligodeoxynucleotides delay the onset of glomerulonephritis and prolong survival in lupus-prone NZB x NZW mice.
    Dong L; Ito S; Ishii KJ; Klinman DM
    Arthritis Rheum; 2005 Feb; 52(2):651-8. PubMed ID: 15692999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased autoantibody production by NZB/NZW B cells in response to IL-5.
    Herron LR; Coffman RL; Bond MW; Kotzin BL
    J Immunol; 1988 Aug; 141(3):842-8. PubMed ID: 2969393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The oncogenic effect of immunosuppressive (cytotoxic) agents in (NZB X NZW) mice. I. Long-term treatment with azathioprine and ifosfamide.
    Mitrou PS; Fischer M; Mitrou G; Röttger P; Holtz G
    Arzneimittelforschung; 1979; 29(3):483-8. PubMed ID: 314806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of autoimmunity in NZB mice by cyclophosphamide-induced, nonspecific suppressor cells.
    Greeley EH; Segre M; Segre D
    J Immunol; 1985 Feb; 134(2):847-51. PubMed ID: 3155543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tolerance defects in New Zealand Black and New Zealand Black X New Zealand White F1 mice.
    McCoy KL; Kendrick L; Chused TM
    J Immunol; 1986 Feb; 136(4):1217-22. PubMed ID: 3944456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention and reversal of lupus in NZB/NZW mice by costimulatory blockade with adeno-associated virus-mediated gene transfer.
    Ye X; Zhu T; Bastacky S; McHale T; Li J; Xiao X
    Arthritis Rheum; 2005 Dec; 52(12):3975-86. PubMed ID: 16329128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic effect of early thymic irradiation in (NZB x NZW)F1 mice, associated with a selective decrease in the levels of IgG3 and gp70-anti-gp70 immune complexes.
    Erausquin C; Merino R; Izui S; Fernandez-Sueiro L; Saez F; Fernandez F; Rodriguez-Valverde V; Merino J
    Cell Immunol; 1995 Apr; 161(2):207-12. PubMed ID: 7697731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmented incidence of neoplasia in female New Zealand black-New Zealand white (NZB-NZW) mice treated with long-term cyclophosphamide.
    Walker SE; Bole GG
    J Lab Clin Med; 1971 Dec; 78(6):978-9. PubMed ID: 4943505
    [No Abstract]   [Full Text] [Related]  

  • 34. Adjuvant polyarthritis. II. Suppression by tilorone.
    Chang YH
    J Pharmacol Exp Ther; 1977 Oct; 203(1):156-61. PubMed ID: 909049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic studies on the skin lupus band test in New Zealand mice.
    Furukawa F; Maruyama N; Yoshida H; Hamashima Y; Hirose S; Shirai T
    Clin Exp Immunol; 1985 Jan; 59(1):146-52. PubMed ID: 3871675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective suppression of autoantibody responses in NZB/NZW mice treated with long-term cyclophosphamide.
    Walker SE; Bole GG
    Arthritis Rheum; 1975; 18(3):265-72. PubMed ID: 1095022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The oncogenic effect of immunosuppressive (cytotoxic) agents in (NZB x NZW) mice. II. Emergence of tumors in young animals treated with azathioprine and ifosfamide, including a histologic assessment of the neoplasms.
    Mitrou PS; Fischer M; Mitrou G; Röttger P
    Arzneimittelforschung; 1979; 29(4):662-7. PubMed ID: 582763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW mice.
    Hahn BH; Knotts L; Ng M; Hamilton TR
    Arthritis Rheum; 1975; 18(2):145-52. PubMed ID: 1131283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of antitumor and antimetastatic activities of alpha-difluoromethylornithine by interferon inducers.
    Sunkara PS; Prakash NJ; Rosenberger AL; Hagan AC; Lachmann PJ; Mayer GD
    Cancer Res; 1984 Jul; 44(7):2799-802. PubMed ID: 6426786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolonged survival of hypertransfused NZB/NZW mice.
    Gabrielsen AE; Olsen CT
    Immunology; 1977 Oct; 33(4):449-52. PubMed ID: 924516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.